200207-21-2

Basic information

• Product Name: 6-DifluoroMethoxyindole
• Synonyms: 6-DifluoroMethoxyindole;6-(Difluoromethoxy)-1H-indole;1H-Indole, 6-(difluoromethoxy)-
• CAS NO: 200207-21-2
• Molecular Formula: C9H7F2NO
• Molecular Weight: 183.1547864
• Mol File: 200207-21-2.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 6-DifluoroMethoxyindole(CAS DataBase Reference)
• NIST Chemistry Reference: 6-DifluoroMethoxyindole(200207-21-2)
• EPA Substance Registry System: 6-DifluoroMethoxyindole(200207-21-2)

Safety Data

• Hazardous Substances Data: 200207-21-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
6-DifluoroMethoxyindole is used as a chemical intermediate for the development of new drug compounds and pharmaceutical products. Its unique structure and properties make it a promising candidate for the synthesis of novel therapeutic agents.
Used in Research Applications:
6-DifluoroMethoxyindole is utilized as a research tool in the scientific community to study its specific properties and potential uses. Ongoing research may reveal further applications for 6-DifluoroMethoxyindole, expanding its utility in various fields.

Upstream product

• 2042-14-0 4-methyl-5-nitrophenol 
• 4637-24-5 N,N-dimethyl-formamide dimethyl acetal 
• 610-78-6 3-nitro-4-chlorophenol 
• 200207-20-1 1-(difluoromethoxy)-3-nitro-4-chlorobenzene 
• 1510828-33-7 tert-butyl 6-(difluoromethoxy)-1H-indole-1-carboxylate 
• 898746-82-2 tert-butyl 6-hydroxy-1H-indole-1-carboxylate 
• 2380-86-1 6-hydroxy-1H-indole 

Downstream Products

• 906642-09-9 C₂₁H₂₁F₂N₃O₃S 
• 876739-53-6 C₂₁H₂₂FN₃O₃S 
• 906641-48-3 C₁₈H₁₅F₂N₃O 
• 906642-06-6 C₂₁H₂₁F₂N₃O₃S 
• 906642-07-7 C₂₁H₁₉F₂N₃O₃S 

Relevant articles and documents

PYRIDINYL AND PYRAZINYL-(AZA)INDOLSULFONAMIDES

The present invention relates to pyridinyl and pyrazinyl-(aza)indolsulfonamides having GPR17 modulator activity. The compounds have utility in the treatment of a variety of GPR17-associated disorders.

QUINUCLIDINES FOR MODULATING ALPHA 7 ACTIVITY

Provided are substituted quinuclidine compounds, pharmaceutical compositions comprising such compounds, and methods of modulating α7 nicotinic acetylcholine receptors and treating neurological disorders using such compounds.

Discovery of N-(4′-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replication

A series of novel 2-phenylindole analogs were synthesized and evaluated for activity in subgenomic HCV replicon inhibition assays. Several compounds containing small alkyl sulfonamides on the phenyl ring exhibiting submicromolar EC50 values against the genotype 1b replicon were identified. Among these, compound 25d potently inhibited the 1b replicon (EC50 = 0.17 μM) with 147-fold selectivity with respect to cytotoxicity. Compound 25d was stable in the presence of human liver microsomes and had a good pharmacokinetic profile in rats with an IV half-life of 4.3 h and oral bioavailability (F) of 58%.